Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of R-Mini-CHP Administered in Combination with Polatuzumab Vedotin (Pola-R-mini-CHP) in Patients ≥80 Years Old with Diffuse Large B-Cell Lymphoma in the Real-World Setting: A Single-Institute Retrospective Study

Yasunobu Sekiguchi, Hiroki Tsutsumi, Masahisa Kudou, Nobuo Maseki, Yoshie Iizaki, Kazuhiko Kobayashi, You Nishimura, Daisuke Takei, Tomoya Abe, Hirofumi Kobayashi

Blood (2024) 144 (Supplement 1): 7822.

https://doi.org/10.1182/blood-2024-205048

Published: 2024

Journal Articles

Phase II/III Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab (R-CHOP) Versus Biweekly CHOP with Rituximab (R-Bi-CHOP) In Untreated Advanced-Stage Indolent B-Cell Lymphoma: Japan Clinical Oncology Group (JCOG) 0203 Trial

Takashi Watanabe, MD, PhD, Yasuo Morishima, MD, PhD, Taro Shibata, MSc, Nobuo Maseki, MD, PhD, Tomohiro Kinoshita, MD, PhD, Takayo Suzuki, MD, PhD, Motoko Yamaguchi, MD, PhD, Kiyoshi Ando, MD, PhD, Michinori Ogura, MD, PhD, Masafumi Taniwaki, MD, PhD, Naokuni Uike, MD, PhD, Kengo Takeuchi, MD, PhD, Shigeru Nawano, MD, PhD, Takashi Terauchi, MD, PhD, Kunihiro Tsukasaki, MD, PhD, Tomomitsu Hotta, MD, PhD, Kensei Tobinai, MD, PhD

Blood (2010) 116 (21): 431.

https://doi.org/10.1182/blood.V116.21.431.431

Published: 2010

Journal Articles

Effects of Extracellular NM23 Protein on In Vitro Survival of Acute Myeloid Leukemia Cells and Normal Peripheral Blood Mononuclear Cells.

Junko Okabe-Kado, PhD, Takashi Kasukabe, PhD, Hirofumi Kobayashi, MD, Nobuo Maseki, MD, Yoshio Honma, PhD, Yasuhiko Kaneko, MD

Blood (2006) 108 (11): 1934.

https://doi.org/10.1182/blood.V108.11.1934.1934

Published: 2006

Journal Articles

Phase I/II Study of Concurrent Chemoradiotherapy for Newly-Diagnosed, Localized Nasal NK/T-Cell Lymphoma: Results of a Phase I Portion of JCOG0211-DI.

Motoko Yamaguchi, Masahiko Oguchi, Kensei Tobinai, Nobuo Maseki, Takayo Suzuki, Yasufumi Masaki, Masanobu Nakata, Hiroyuki Hata, Noriko Usui, Izumi Wasada, Yoshikazu Kagami, Shigeo Nakamura, Tomomitsu Hotta, Kazuo Oshimi, The Japan Clinical Oncology Group - Lymphoma Study Group (JCOG-LSG) Japan.

Blood (2005) 106 (11): 2685.

https://doi.org/10.1182/blood.V106.11.2685.2685

Published: 2005

Journal Articles

Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia

Nozomi Niitsu, Junko Okabe-Kado, Michihiro Nakayama, Naoki Wakimoto, Akiko Sakashita, Nobuo Maseki, Kazuo Motoyoshi, Masanori Umeda, Yoshio Honma

Blood (2000) 96 (3): 1080–1086.

https://doi.org/10.1182/blood.V96.3.1080

Published: 2000

Journal Articles

AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon

Kimiko Shimizu, Issay Kitabayashi, Nanao Kamada, Tatsuo Abe, Nobuo Maseki, Kazumi Suzukawa, Misao Ohki

Blood (2000) 96 (1): 288–296.

https://doi.org/10.1182/blood.V96.1.288

Published: 2000

Journal Articles

Evaluation by Multivariate Analysis of the Differentiation Inhibitory Factor nm23 as a Prognostic Factor in Acute Myelogenous Leukemia and Application to Other Hematologic Malignancies

Akihiro Yokoyama, Junko Okabe-Kado, Naoki Wakimoto, Hirofumi Kobayashi, Akiko Sakashita, Nobuo Maseki, Tsuyoshi Nakamaki, Ken-ichiro Hino, Shigeru Tomoyasu, Nobuyoshi Tsuruoka, Kazuo Motoyoshi, Naokazu Nagata, Yoshio Honma

Blood (1998) 91 (6): 1845–1851.

https://doi.org/10.1182/blood.V91.6.1845

Published: 1998

Journal Articles

Consistent Detection of TLS/FUS-ERG Chimeric Transcripts in Acute Myeloid Leukemia With t(16; 21)(p11; q22) and Identification of a Novel Transcript

Xiao-Tang Kong, Kohmei Ida, Hitoshi Ichikawa, Kimiko Shimizu, Misao Ohki, Nobuo Maseki, Yasuhiko Kaneko, Masahiro Sako, Yukio Kobayashi, Arinobu Tojou, Ikuo Miura, Harumi Kakuda, Tetsunori Funabiki, Keizo Horibe, Hiroyuki Hamaguchi, Yuichi Akiyama, Fumio Bessho, Masayoshi Yanagisawa, Yasuhide Hayashi

Blood (1997) 90 (3): 1192–1199.

https://doi.org/10.1182/blood.V90.3.1192

Published: 1997

NARROW

Efficacy and Safety of R-Mini-CHP Administered in Combination with Polatuzumab Vedotin (Pola-R-mini-CHP) in Patients ≥80 Years Old with Diffuse Large B-Cell Lymphoma in the Real-World Setting: A Single-Institute Retrospective Study

Phase II/III Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab (R-CHOP) Versus Biweekly CHOP with Rituximab (R-Bi-CHOP) In Untreated Advanced-Stage Indolent B-Cell Lymphoma: Japan Clinical Oncology Group (JCOG) 0203 Trial

Effects of Extracellular NM23 Protein on In Vitro Survival of Acute Myeloid Leukemia Cells and Normal Peripheral Blood Mononuclear Cells.

Phase I/II Study of Concurrent Chemoradiotherapy for Newly-Diagnosed, Localized Nasal NK/T-Cell Lymphoma: Results of a Phase I Portion of JCOG0211-DI.

Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia

AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon

Evaluation by Multivariate Analysis of the Differentiation Inhibitory Factor nm23 as a Prognostic Factor in Acute Myelogenous Leukemia and Application to Other Hematologic Malignancies

Consistent Detection of TLS/FUS-ERG Chimeric Transcripts in Acute Myeloid Leukemia With t(16; 21)(p11; q22) and Identification of a Novel Transcript

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only